A new drug combination has been found to be effective in treating men with advanced prostate cancer. The combination has been shown to improve survival and delay the progression of the disease, with some reports suggesting it can lower the risk of death by a significant amount. The specifics of the treatment and its benefits are still being reported, with some outlets citing specific data and others highlighting its potential as a promising development in cancer treatment.